Article
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
International journal of cancer - 15 Jan 2024
Inturrisi Federica, de Sanjosé Silvia, Desai Kanan T, Dagnall Casey, Egemen Didem, Befano Brian, Rodriguez Ana Cecilia, Jeronimo Jose A, Zuna Rosemary E, Hoffman Amanda, Farhat Nozzari Sepideh, Walker Joan L, Perkins Rebecca B, Wentzensen Nicolas, Palefsky Joel M, Schiffman Mark
Abstract excerpt
The World Health Organization recommends human papillomavirus (HPV) testing for cervical screening. Extended genotyping can identify the highest-risk HPV-positive women. An inexpensive, rapid, mobile isothermal amplification assay (ScreenFire HPV RS test) was recently redesigned to yield four channels ordered by cancer risk (ie, hierarchical approach): HPV16, HPV18/45, HPV31/33/35/52/58 and HPV39/51/56/59/68....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
